William E. Bindley - 20 Mar 2026 Form 4 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: GRDN
Reported as of: 20 Mar 2026
Net transaction value: -$105,986,620
SEC form: 4
Accepted by SEC: 24 Mar 2026, 16:15:03 UTC
Prior SEC filing: 30 Sep 2025
Next SEC filing: 31 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Douglas Towns, Attorney-in-Fact

Key filing fact

William E. Bindley filed Form 4 for Guardian Pharmacy Services, Inc. (GRDN) on 24 Mar 2026.

Key facts

This page summarizes William E. Bindley's Form 4 filing for Guardian Pharmacy Services, Inc. (GRDN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Mar 2026, 16:15.

Change

Previous filing in this sequence was filed on 30 Sep 2025.
Current net transaction value: -$105,986,620.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000903539 Primary reporting owner

BINDLEY WILLIAM E

Relationship: Director, 10%+ Owner
Address: 300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA
Signature: /s/ Douglas Towns, Attorney-in-Fact
Signature date: 24 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GRDN transaction

Class A Common Stock

Sale

Transaction value: $105,986,620
Shares: -3,570,677
Change %: -44%
Price: $29.68
Shares after: 4,469,316
Date: 20 Mar 2026
Ownership: By Bindley Capital Partners I, LLC
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.